Sonia L. Egbert

Ms. Egbert has more than 26 years of experience in the fields of accounting and finance, which includes working with start-up pharmaceutical companies. Prior to joining Summit Biosciences in 2009, Ms. Egbert served as the Controller at Intranasal Therapeutics, Inc. ("ITI") where she was responsible for Board of Director and investor reporting; cash management; banking, insurance and investor relations; accounting controls; budgeting and forecasting. Prior to ITI, Ms. Egbert was Treasurer and Controller at a successful start-up web-based transportation company. Ms. Egbert also held various director-level positions at a fortune 200 transportation company (BNSF) in the finance, accounting and forecasting and planning departments where she was involved with merger transactions, SEC reporting, managing revenue and capital budgets. Ms. Egbert worked for Deloitte & Touche at various levels in their audit group in both the Minneapolis and Dallas offices. Ms. Egbert holds a Bachelor of Business Administration degree from the University of Wisconsin Eau-Claire and is a CPA.